Following the appointment that Raf Beeren becomes Managing Director of Hendrix Genetics’ Business Unit Turkeys, Hypor is pleased to appoint Luis Prieto Garcia as Managing Director of the Business Unit Swine.

Prieto will report to Hendrix Genetics CEO Antoon van den Berg beginning January 1, 2018. After almost two decades working in various capacities for Hypor in Spain, Mexico and Canada, Prieto brings a wealth of experience in business and management to his new position. In 2012 Luis was appointed General Manager Americas and member of the management team of Hendrix Genetics Business Unit Swine. “We are thrilled to have someone with Luis’ background in this critical role,” says Antoon van den Berg.

Prieto graduated from the Veterinary University in Léon, Spain and holds a Veterinary Medicine Degree and a Master’s Degree in pig production. He started his career with Hypor Spain as a technical specialist (veterinarian) in 1999 and has been a key member of the Hypor family ever since.

In spite of his many years in the industry, Luis is only 42 years old. He lives with his wife and daughter in Regina, Canada. “With his experience in production, sales and business development, Luis adds great value to our company and our clients. He has a keen understanding of Hypor’s business model and shares our commitment to total system profitability for all customers.”

Hypor is one of the world's leading suppliers of pig genetics. Committed to providing superior genetics that supports profitability in the pork value chain. With its Head Office located in Boxmeer, The Netherlands, Hypor has strategically-located and interconnected breeding centers in North America, Europe and Asia. More information is available at www.hypor.com

Hypor is part of Hendrix Genetics, a leading multi-species breeding company with primary activities in layer-, turkey-, swine-, aquaculture -and traditional poultry breeding. Headquartered in Boxmeer, in The Netherlands, Hendrix Genetics provides expertise and resources to producers in more than 100 countries, with operations and joint ventures in more than 35 countries and more than 3.000 employees worldwide. More information is available at www.hendrix-genetics.com